Recent investigations indicate a notable correlation between the increased expression of hepatic CD36 and insulin resistance, hyperinsulinemia, and heightened steatosis in NASH [62]. The gene discussed is CD36; the disease is metabolic dysfunction-associated steatohepatitis.